Dana Farber Cancer Institute
Dr Shayna Sarosiek is a hematology/oncologist who specializes in the treatment of patients with Waldenström macroglobulinemia and other IgM related disorders, including AL amyloidosis. She completed her residency as well as her hematology & oncology fellowship at Boston University Medical Center. During her time there she also completed a fellowship in Amyloidosis and then continued her work as a faculty member at Boston University Medical center before moving to her current position. She is now an Assistant Professor at Harvard Medical School and a practicing physician at the Bing Center for Waldenström macroglobulinemia at Dana Farber Cancer Institute. She is involved in the care of patients with Waldenström macroglobulinemia, but is also actively involved in clinical research and clinical trials.
ADC Therapeutics (Individual(s) Involved: Self; Clinical Condition: Oncology): ; BeiGene (Individual(s) Involved: Self; Clinical Condition: Oncology):